# 🧬 OncoNexa

## AI-Powered Pan-Cancer Biomarker Discovery Platform

**OncoNexa** is a computational bioinformatics platform designed to support **cancer biomarker discovery, validation, prioritization, and biological interpretation** from gene-expression data.

The platform brings together statistical analysis, machine learning, pathway analysis, biomarker validation, evidence integration, and AI-assisted interpretation into a single research-oriented workflow.

> **Public launch — September 2026**

---

## 🧬 Explore OncoNexa

### Free Lung Cancer Demonstration

A public lung-cancer demonstration is available so researchers, students, and interested users can explore the OncoNexa workflow and understand how the platform analyzes expression data.

The demonstration provides access to a prepared research dataset and allows users to explore the analytical workflow without submitting their own data.

**Try the public demonstration:**
https://onconexa-platform.streamlit.app/

---

## 🔒 Want to Analyze Your Own Data?

Customer data analysis is available through a **request-based workflow**.

If you have your own gene-expression dataset and would like to use OncoNexa for biomarker discovery or validation, submit an analysis request through the platform.

### Request workflow

**1. Submit a request**
Provide information about your dataset, cancer type, research objective, and analysis requirements.

**2. Discuss the analysis**
The project requirements and appropriate computational workflow can be reviewed before analysis begins.

**3. Submit the dataset**
Customer data can be provided according to the agreed analysis workflow and data requirements.

**4. Computational analysis**
OncoNexa applies the appropriate statistical, machine-learning, validation, pathway, and biomarker-prioritization modules.

**5. Results & reporting**
Results can be explored through the platform and used to support downstream research and experimental planning.

---

# 🔬 Platform Capabilities

OncoNexa provides an integrated workflow for computational biomarker research.

### 1. Data Upload & Validation

Supports customer-provided gene-expression datasets with optional metadata.

The workflow is designed to help establish appropriate sample groups and prepare the dataset for downstream analysis.

### 2. Differential Expression Analysis

Identify genes showing statistically significant expression differences between relevant experimental or biological groups.

The platform supports established statistical workflows, including R-based differential-expression analysis where appropriate.

### 3. Biomarker Explorer

Explore candidate biomarkers using statistical and biological characteristics to help researchers investigate potentially informative genes.

### 4. ROC & Biomarker Validation

Evaluate candidate biomarkers using classification and ROC-based analyses to investigate their ability to distinguish relevant sample groups.

### 5. Machine Learning

Machine-learning workflows can be used to investigate predictive biomarker signatures and evaluate candidate features.

### 6. Stability Analysis

Assess the consistency of biomarker candidates and model-derived features across computational iterations or resampling strategies.

### 7. Pathway Analysis

Investigate biological pathways and functional processes associated with candidate biomarkers and differentially expressed genes.

### 8. Biomarker Ranking

Integrate multiple analytical signals to help researchers prioritize candidate biomarkers for further investigation.

### 9. Evidence Integration

Bring computational findings together with biological and research evidence to support interpretation and prioritization.

### 10. AI Biomarker Assistant

An AI-assisted interface helps researchers interpret analytical findings, explore candidate biomarkers, and generate research-oriented biological insights.

AI-generated interpretations should be treated as **research assistance rather than independent scientific validation**.

### 11. Results & Reporting

Analytical results can be explored through the platform and prepared for downstream research, documentation, and reporting.

---

# 🧪 OncoNexa Analysis Workflow

```text
Gene-Expression Data
        │
        ▼
Data Upload & Validation
        │
        ▼
Differential Expression
        │
        ▼
Candidate Biomarker Exploration
        │
        ├──────────────► ROC / Validation
        │
        ├──────────────► Machine Learning
        │
        ├──────────────► Stability Analysis
        │
        ├──────────────► Pathway Analysis
        │
        └──────────────► Evidence Integration
                         │
                         ▼
                 Biomarker Prioritization
                         │
                         ▼
                AI-Assisted Interpretation
                         │
                         ▼
                  Results & Reporting
```

---

# 🧬 Research Applications

OncoNexa is designed to support research workflows including:

* Cancer biomarker discovery
* Diagnostic biomarker research
* Gene-expression analysis
* Transcriptomic research
* Candidate biomarker validation
* Biomarker prioritization
* Machine-learning-based biomarker exploration
* Pathway and functional analysis
* Comparative tumor/control studies
* Computational oncology research
* Research hypothesis generation
* Preparation for downstream experimental validation

The platform is intended to be applicable across **multiple cancer types**, depending on the dataset and research question.

---

# 📊 Input Data

OncoNexa is designed primarily around gene-expression analysis.

Typical inputs can include:

* Gene-expression matrices in CSV format
* Sample-level metadata
* Biological or experimental group information
* Tumor/control or other study-specific comparisons

The exact data requirements depend on the requested analysis.

### Data quality matters

The quality and interpretation of computational results depend on factors including:

* Experimental design
* Sample size
* Data preprocessing
* Normalization
* Batch effects
* Biological heterogeneity
* Group definitions
* Quality of metadata

Appropriate preprocessing and experimental context should therefore be considered before interpreting results.

---

# 🧠 Technology

OncoNexa combines established bioinformatics methods with statistical computing, machine learning, and AI-assisted interpretation.

### Core technologies

* **Python**
* **R**
* **Streamlit**
* **Pandas**
* **NumPy**
* **Scikit-learn**
* Statistical genomics workflows
* Differential-expression analysis
* Machine learning
* ROC analysis
* Pathway and functional analysis
* Bioinformatics workflows
* AI-assisted research interpretation

---

# 🏗️ Platform Architecture

The main application is organized into modular analytical components.

```text
dashboard_v2/
│
├── app.py
│
├── core/
│   ├── analysis_engine.py
│   ├── customer_context.py
│   └── user_data.py
│
└── views/
    ├── data_upload.py
    ├── differential_expression.py
    ├── biomarker_explorer.py
    ├── roc_validation.py
    ├── machine_learning.py
    ├── stability.py
    ├── pathway.py
    ├── ranking.py
    ├── evidence.py
    ├── ai_assistant.py
    ├── downloads.py
    └── pricing.py
```

The architecture is designed around separate analytical modules so that additional computational workflows can be incorporated as the platform develops.

---

# 🌐 Public Demonstration

The public demonstration provides an accessible way to explore the platform before requesting customer analysis.

### Current public access

**OncoNexa:**
https://onconexa-platform.streamlit.app/

The public demonstration uses a prepared lung-cancer research dataset.

It is intended for **platform exploration and demonstration purposes** and should not be interpreted as a clinical diagnostic service.

---

# 💼 Research & Commercial Analysis

OncoNexa is being developed as a platform for researchers, biotechnology teams, academic groups, and other organizations requiring computational biomarker analysis.

Potential use cases include:

* Independent research projects
* Biomarker discovery programs
* Transcriptomic investigations
* Computational oncology projects
* Early-stage biotechnology research
* Candidate prioritization
* Research data interpretation
* Computational support before experimental validation

Customer analysis is handled through a request-based workflow so that the analysis can be aligned with the dataset, biological question, and intended research objective.

---

# 🔐 Data & Privacy

Customer data should only be submitted through an agreed analysis workflow and with appropriate authorization.

Users should **not upload confidential, personally identifiable, or otherwise restricted data without appropriate authorization and data-governance arrangements**.

The platform is designed around customer-specific analysis workflows rather than exposing customer datasets as public demonstration data.

Generated local test data and customer-specific analysis outputs are excluded from the public source repository.

---

# 🚧 Current Development Status

OncoNexa is an **actively developing computational research platform**.

The current public release includes:

* Public lung-cancer demonstration
* Customer analysis request workflow
* Gene-expression data upload
* Differential-expression analysis
* Biomarker exploration
* ROC/validation analysis
* Machine-learning workflows
* Stability analysis
* Pathway analysis
* Biomarker ranking
* Evidence integration
* AI Biomarker Assistant
* Results and reporting functionality

The complete public workflow has been tested using public research data.

Additional analytical capabilities and research workflows may be added as development continues.

---

# 🔬 Scientific Interpretation & Limitations

OncoNexa provides computational results intended to support scientific research.

Computationally identified biomarkers are **candidate findings**, not automatically clinically validated biomarkers.

Results depend on the underlying dataset, study design, preprocessing, statistical assumptions, and biological context.

OncoNexa does **not** replace:

* Experimental validation
* Independent cohort validation
* Clinical validation
* Regulatory assessment
* Expert scientific review
* Medical diagnosis or clinical decision-making

Researchers should independently evaluate and validate findings before using them for downstream scientific or clinical purposes.

---

# 🎯 Development Vision

The long-term goal of OncoNexa is to develop a flexible computational environment that helps researchers move from:

**Raw biological data → Statistical evidence → Candidate biomarkers → Validation → Biological interpretation → Research prioritization**

The platform is intended to grow beyond individual cancer demonstrations toward broader **pan-cancer computational biomarker research**.

Future development may include additional data types, multi-omics workflows, advanced machine learning, expanded biological evidence integration, and more sophisticated research automation.

---

# 🤝 Collaboration & Analysis Requests

Researchers, biotechnology teams, and organizations interested in using OncoNexa for their own datasets can submit a request through the public platform.

### Start here

**Explore the demonstration:**
https://onconexa-platform.streamlit.app/

**Own dataset analysis:**
Use the **Request Analysis** workflow available within the platform.

---

# 📄 Repository

This repository contains the development code and supporting resources for the OncoNexa platform.

Generated customer analysis outputs, local test datasets, temporary files, and development backups are intentionally excluded from version control.

---

# ⚠️ Disclaimer

OncoNexa is a **research-oriented computational bioinformatics platform**.

The platform does not provide medical diagnosis, treatment recommendations, or clinically validated diagnostic results.

Any biomarker or biological insight generated by the platform should be considered a computational research finding and should undergo appropriate independent scientific and experimental validation before clinical or other high-stakes use.

---

## OncoNexa

**AI-assisted computational biomarker discovery, validation, and biological insight.**

*From expression data to research-ready biomarker insights.*
